Bassler Bonnie L
SEC CIK 1683607 · EDGAR
BoughtSold
Most active insiders at RPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coyne Terrance P. | EVP, CFO | — | $38.96M |
| 2 | Hite Christopher | EVP, Vice COB | — | $27.36M |
| 3 | Lloyd George W. | EVP, CLO, Investments | — | $13.81M |
| 4 | Urist Marshall | EVP, Research, Investments | — | $12.07M |
| 5 | Norden Gregory | Dir | — | $161.4K |
| 6 | Engelbert Catherine M. | Dir | — | — |
| 7 | Ho Carole | Dir | — | — |
| 8 | Coric Vlad | Dir | — | — |
| 9 | Bassler Bonnie L | Dir | — | — |
| 10 | Legorreta Pablo G. | CEO, COB, Dir | — | — |
Transactions 72
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 17:15 | 2026-06-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $54.40 | +689 | 79.2K | +0.9% | +$37.5K | |
| 2026-06-08 16:20 | 2026-06-05 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $0.00 | +4,545 | 78.5K | +6% | $0 | |
| 2026-03-31 | 2026-03-31 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $45.98 | +815 | 73.9K | +1% | +$37.5K | |
| D | 2026-01-08 | 2026-01-07 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $800.00 | -1,500 | 1,703 | -47% | -$1.20M |
| D | 2026-01-08 | 2026-01-07 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $374.12 | +1,500 | 3,203 | +88% | +$561.2K |
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | A - Grant | $0.00 | +155 | 1,703 | +10% | $0 |
| 2026-01-02 | 2025-12-31 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $38.74 | +967 | 73.1K | +1% | +$37.5K | |
| D | 2025-11-24 | 2025-11-20 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $750.00 | -760 | 1,548 | -33% | -$570.0K |
| D | 2025-11-24 | 2025-11-20 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $371.40 | +760 | 2,308 | +49% | +$282.3K |
| 2025-09-30 | 2025-09-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $35.79 | +1,047 | 72.2K | +1% | +$37.5K | |
| 2025-06-30 | 2025-06-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $35.24 | +1,064 | 71.1K | +2% | +$37.5K | |
| 2025-05-14 | 2025-05-13 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $0.00 | +7,614 | 70.1K | +12% | $0 | |
| 2025-04-01 | 2025-03-31 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $32.87 | +1,141 | 62.4K | +2% | +$37.5K | |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | A - Grant | $0.00 | +166 | 1,548 | +12% | $0 |
| 2025-01-02 | 2024-12-31 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $24.94 | +1,503 | 61.3K | +3% | +$37.5K | |
| 2024-09-30 | 2024-09-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $27.92 | +1,342 | 59.8K | +2% | +$37.5K | |
| D | 2024-08-19 | 2024-08-15 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $1,170.00 | -756 | 1,382 | -35% | -$884.5K |
| D | 2024-08-19 | 2024-08-15 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $371.40 | +756 | 2,138 | +55% | +$280.8K |
| D | 2024-08-05 | 2024-08-02 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $371.40 | +756 | 2,138 | +55% | +$280.8K |
| D | 2024-08-05 | 2024-08-02 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $1,115.00 | -756 | 1,382 | -35% | -$842.9K |
| 2024-06-28 | 2024-06-28 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $26.80 | +1,399 | 58.5K | +2% | +$37.5K | |
| D | 2024-06-25 | 2024-06-24 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $371.40 | +756 | 2,138 | +55% | +$280.8K |
| D | 2024-06-25 | 2024-06-24 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $1,062.00 | -756 | 1,382 | -35% | -$802.9K |
| 2024-06-10 | 2024-06-07 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $0.00 | +9,293 | 57.1K | +19% | $0 | |
| D | 2024-06-07 | 2024-06-05 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +827 | 2,209 | +60% | +$315.0K |
| D | 2024-06-07 | 2024-06-05 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $1,011.00 | -827 | 1,382 | -37% | -$836.1K |
| 2024-04-02 | 2024-03-28 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $30.23 | +1,240 | 47.8K | +3% | +$37.5K | |
| D | 2024-02-26 | 2024-02-26 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $391.92 | +854 | 2,236 | +62% | +$334.7K |
| D | 2024-02-26 | 2024-02-26 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $979.25 | -854 | 1,382 | -38% | -$836.3K |
| D | 2024-01-31 | 2024-01-30 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +827 | 2,209 | +60% | +$315.0K |
| D | 2024-01-31 | 2024-01-30 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $959.00 | -827 | 1,382 | -37% | -$793.1K |
| D | 2024-01-04 | 2024-01-03 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $914.00 | -826 | 1,382 | -37% | -$755.0K |
| D | 2024-01-04 | 2024-01-03 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +826 | 2,208 | +60% | +$314.7K |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | A - Grant | $0.00 | +135 | 1,382 | +11% | $0 |
| 2023-12-29 | 2023-12-29 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $27.71 | +1,353 | 46.5K | +3% | +$37.5K | |
| D | 2023-12-14 | 2023-12-13 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $376.69 | +610 | 1,857 | +49% | +$229.8K |
| D | 2023-12-14 | 2023-12-13 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $870.00 | -610 | 1,247 | -33% | -$530.7K |
| 2023-10-03 | 2023-09-29 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $27.08 | +1,384 | 45.2K | +3% | +$37.5K | |
| D | 2023-08-23 | 2023-08-21 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $391.92 | +853 | 2,100 | +68% | +$334.3K |
| D | 2023-08-23 | 2023-08-21 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $829.00 | -853 | 1,247 | -41% | -$707.1K |
| D | 2023-08-11 | 2023-08-10 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $789.00 | -853 | 1,247 | -41% | -$673.0K |
| D | 2023-08-11 | 2023-08-10 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $391.92 | +853 | 2,100 | +68% | +$334.3K |
| 2023-06-30 | 2023-06-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $31.03 | +1,208 | 43.8K | +3% | +$37.5K | |
| 2023-06-26 | 2023-06-23 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $0.00 | +7,747 | 42.6K | +22% | $0 | |
| 2023-03-31 | 2023-03-31 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $35.73 | +1,049 | 34.8K | +3% | +$37.5K | |
| D | 2023-03-27 | 2023-03-24 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +1,240 | 2,487 | +99% | +$472.4K |
| D | 2023-03-27 | 2023-03-24 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $818.00 | -1,240 | 1,247 | -50% | -$1.01M |
| D | 2023-02-07 | 2023-02-03 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $779.00 | -1,021 | 1,247 | -45% | -$795.4K |
| D | 2023-02-07 | 2023-02-03 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +1,021 | 2,268 | +82% | +$388.9K |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | A - Grant | $0.00 | +165 | 1,247 | +15% | $0 |
| 2023-01-03 | 2022-12-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $39.76 | +943 | 33.8K | +3% | +$37.5K | |
| D | 2022-12-12 | 2022-12-08 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $779.00 | -218 | 1,082 | -17% | -$169.8K |
| D | 2022-12-12 | 2022-12-08 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +218 | 1,300 | +20% | +$83.0K |
| 2022-09-30 | 2022-09-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $41.06 | +913 | 32.8K | +3% | +$37.5K | |
| DM | 2022-09-12 | 2022-09-08+ | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $704.65 | -3,167 | 1,082 | -75% | -$2.23M |
| DM | 2022-09-12 | 2022-09-08+ | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $388.99 | +3,167 | 2,361 | New | +$1.23M |
| 2022-06-30 | 2022-06-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $41.52 | +903 | 31.9K | +3% | +$37.5K | |
| 2022-06-24 | 2022-06-24 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $0.00 | +6,328 | 31.0K | +26% | $0 | |
| D | 2022-04-11 | 2022-04-07 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +1,240 | 2,322 | +115% | +$472.4K |
| D | 2022-04-11 | 2022-04-07 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $725.00 | -1,240 | 1,082 | -53% | -$899.0K |
| 2022-04-01 | 2022-03-31 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $38.87 | +964 | 24.7K | +4% | +$37.5K | |
| D | 2022-04-01 | 2022-03-30 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +1,240 | 2,322 | +115% | +$472.4K |
| D | 2022-04-01 | 2022-03-30 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $700.00 | -1,240 | 1,082 | -53% | -$868.0K |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | A - Grant | $0.00 | +191 | 1,082 | +21% | $0 |
| 2022-01-03 | 2021-12-31 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $39.11 | +958 | 23.7K | +4% | +$37.5K | |
| 2021-09-30 | 2021-09-30 | RPRX | Royalty Pharma plc | Bassler Bonnie L | Dir | A - Grant | $37.80 | +992 | 22.8K | +5% | +$37.5K | |
| D | 2021-08-17 | 2021-08-16 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $376.69 | +1,219 | 2,110 | +137% | +$459.2K |
| D | 2021-08-17 | 2021-08-16 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $630.00 | -1,219 | 891 | -58% | -$768.0K |
| D | 2021-08-06 | 2021-08-05 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $391.92 | +2,559 | 3,450 | +287% | +$1.00M |
| D | 2021-08-06 | 2021-08-05 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $600.00 | -2,559 | 891 | -74% | -$1.54M |
| D | 2021-07-02 | 2021-07-01 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | M - OptEx | $391.92 | +2,558 | 3,449 | +287% | +$1.00M |
| D | 2021-07-02 | 2021-07-01 | REGN | Regeneron Pharmaceuticals | Bassler Bonnie L | Dir | S - Sale+OE | $575.00 | -2,558 | 891 | -74% | -$1.47M |
Purchase Sale Sale after option exercise All abbreviations